Pfizer Animal Health announced the availability of E. coli Bacterial Extract vaccine* with SRP® technology, the first vaccine demonstrated to reduce E. coli O157 shedding and prevalence at the source — inside the cattle.
E. Coli Bacterial Extract vaccine with SRP technology is an effective management tool to reduce the prevalence and shedding of E. coli O157 without any production setbacks. Data from a recently published study indicated that vaccination at the feedlot reduced E. coli O157 contamination among cattle by 85%. Of those cattle still positive for E. coli O157, there was a 98% reduction in total remaining pathogen load.
E. coli is an economically devastating problem that has resulted in billions of dollars in lost demand and costs associated with recalls. The beef industry spends more than $350 million annually on improving beef safety, and much of this effort goes toward E. coli O157.3
E. Coli Bacterial Extract vaccine with SRP® technology is manufactured by Epitopix LLC. Pfizer Animal Health acquired global rights to the vaccine earlier this year and is the exclusive distributor. For more information, producers should contact their Pfizer Animal Health representative or their veterinarian.